Literature DB >> 4015321

Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. A family study using DSM-III criteria.

K S Kendler, A M Gruenberg, M T Tsuang.   

Abstract

This report examines the risk for psychiatric illness in 723 first-degree relatives of schizophrenics and 1,056 first-degree relatives of matched surgical control patients. Diagnoses in patients and relatives were made "blind" to one another, using DSM-III criteria. Information on relatives was obtained from personal interview and/or hospital records. Results were analyzed using two levels of diagnostic certainty and with or without relatives on whom only hospital records were obtained. In all analyses, the risk for schizophrenia was significantly greater (at least 18-fold) in the relatives of schizophrenics v controls. Evidence was also found for an increased risk in relatives of schizophrenics for schizoaffective disorder, paranoid disorder, and atypical psychosis but not for unipolar disorder, anxiety disorder, or alcoholism. As defined by DSM-III, schizophrenia is a familial disorder; however, the increased risk for psychotic illness in relatives of schizophrenics does not appear to be confined to schizophrenia alone.

Entities:  

Mesh:

Year:  1985        PMID: 4015321     DOI: 10.1001/archpsyc.1985.01790310032004

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  29 in total

1.  Smoking and schizophrenia in population cohorts of Swedish women and men: a prospective co-relative control study.

Authors:  Kenneth S Kendler; Sara Larsson Lönn; Jan Sundquist; Kristina Sundquist
Journal:  Am J Psychiatry       Date:  2015-06-05       Impact factor: 18.112

Review 2.  Interpretations of schizophrenia.

Authors:  R J Barrett
Journal:  Cult Med Psychiatry       Date:  1988-09

Review 3.  The common genetic liability between schizophrenia and bipolar disorder: a review.

Authors:  E Bramon; P C Sham
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

Review 4.  The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.

Authors:  John H Krystal; D Cyril D'Souza; Jürgen Gallinat; Naomi Driesen; Anissa Abi-Dargham; Ismene Petrakis; Andreas Heinz; Godfrey Pearlson
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

5.  Stability and prediction of schizophrenia from adolescence to adulthood.

Authors:  Margareth I Helgeland; Svenn Torgersen
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-03       Impact factor: 4.785

6.  Dynamic brain network reconfiguration as a potential schizophrenia genetic risk mechanism modulated by NMDA receptor function.

Authors:  Urs Braun; Axel Schäfer; Danielle S Bassett; Franziska Rausch; Janina I Schweiger; Edda Bilek; Susanne Erk; Nina Romanczuk-Seiferth; Oliver Grimm; Lena S Geiger; Leila Haddad; Kristina Otto; Sebastian Mohnke; Andreas Heinz; Mathias Zink; Henrik Walter; Emanuel Schwarz; Andreas Meyer-Lindenberg; Heike Tost
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

7.  Using the high-risk family design to identify biomarkers for major depression.

Authors:  Ardesheer Talati; Myrna M Weissman; Steven P Hamilton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

8.  Evidence for anticipation in schizophrenia.

Authors:  A S Bassett; W G Honer
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

9.  Tailoring the definition of the clinical schizophrenia phenotype in linkage studies.

Authors:  Verena Krause; Olga Krastoshevsky; Michael J Coleman; J Alexander Bodkin; Jan Lerbinger; Lenore Boling; Fred Johnson; Anne Gibbs; Jonathan O Cole; Zhuying Huang; Nancy R Mendell; Deborah L Levy
Journal:  Schizophr Res       Date:  2009-11-26       Impact factor: 4.939

10.  Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137.

Authors:  Albert H Kim; Erin K Parker; Vernell Williamson; Gowon O McMichael; Ayman H Fanous; Vladimir I Vladimirov
Journal:  Schizophr Res       Date:  2012-08-09       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.